← Back to Patent Explorer
US4215039A Expired / Lapsed US ⏱️ 0.0 years remaining

Somatostatin analogues

Assignee: Wyeth LLC
•
Filing: 1979-02-15
•
Granted: 1980-07-29
•
Expires: 1999-02-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract ##STR1## the linear precursor intermediates therefor or non-toxic acid addition salts thereof in which X 2 is H, NH 2 , Ala--Gly--, Ala--D--Ala--, Gly--Gly--Gly--, lower alkanoyl or benzoyl; X 4 is Arg, His or Lys; X 5 is His, Tyr or Glu; X 8 is Trp or D-Trp; X 10 is Val, α-Abu, Leu, Phe or Tyr; and X 14 is Cys, D-Cys or --NH(CH 2 ) 2 --S--, inhibit the release of growth hormone and glucagon without substantial decrease in insulin and are useful in the treatment of acromegaly and diabetes.

Inventors

  • 👤 Dimitrios Sarantakis

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 23:03
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/655; C07K14/6555; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/16

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 73 words
A compound of the formula: ##STR4## its linear precursor intermediates or non-toxic acid addition salts thereof in which X 2 is H, NH 2 , Ala--Gly--, Ala--D--Ala, Gly--Gly--Gly--, lower alkanoyl or benzoyl; X 4 is Arg, His or Lys; X 5 is His, Tyr or Glu; X 8 is Trp or D--Trp; X 10 is Val, α--Abu, Leu, Phe or Tyr; and X 14 is Cys, D--Cys or --NH(CH 2 ) 2 --S--.
Claim 2
Dependent Claim 73 words
A compound of the formula: ##STR4## its linear precursor intermediates or non-toxic acid addition salts thereof in which X 2 is H, NH 2 , Ala--Gly--, Ala--D--Ala, Gly--Gly--Gly--, lower alkanoyl or benzoyl; X 4 is Arg, His or Lys; X 5 is His, Tyr or Glu; X 8 is Trp or D--Trp; X 10 is Val, α--Abu, Leu, Phe or Tyr; and X 14 is Cys, D--Cys or --NH(CH 2 ) 2 --S--.
Claim 3
Dependent Claim 14 words
The compound of claim 1 in which X 10 is Val, α-Abu or Leu.
Claim 4
Dependent Claim 24 words
The compound of claim 1 which is [des--Ala 1 --Gly 2 , Arg 4 , His 5 , D-Trp 8 , Val 10 ]somatostatin.
Claim 5
Dependent Claim 24 words
The compound of claim 1 which is [des--Ala 1 --Gly 2 , Arg 4 , Glu 5 , D-Trp 8 , α-Abu 10 ]somatostatin.
Claim 6
Dependent Claim 203 words
A compound of Claim 1 of the formula: ##STR5## in which R is hydrogen, an α-amino protecting group, lower alkanoyl or benzoyl; R 1 and R 8 are hydrogen or a thio protecting group; R 2 is hydrogen or a protecting group for N g of Arg, N im of His or the amino group of Lys; R 3 is hydrogen or a protecting group for N im of His or the hydroxyl group of Tyr; R 4 is hydrogen or an amino protecting group; R 5 is hydrogen or a hydroxyl protecting group for Tyr; R 6 and R 7 are hydrogen or a hydroxyl protecting group for Thr and Ser; where Y 2 is Ala--Gly--, Ala--D--Ala--or Gly--Gly--Gly--; n is 0 or 1; X 4 is Arg, His or Lys; X 5 is His, Tyr or Glu; X 8 is Trp or D-Trp; X 10 is Val, α-Abu, Leu, Phe or Tyr; Y 14 is Cys or D-Cys; p is 0 or 1 and Z is --OH or --O--CH 2 --[polystyrene resin support] with the proviso that R--R 7 are hydrogen when Z is --OH and R 1 -R 7 are other than hydrogen when Z is --O--CH 2 --[polystyrene resin support].
Claim 7
Dependent Claim 16 words
The compound of claim 1 which is tert-Butyloxycarbonyl-S-p-methoxybenzyl-L-cysteinyl-N g -toxyl-L-arginyl-N im -tosyl-L-histidyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-N.sup..epsilon. -2-chlorobenzyloxycarbonyl-L-lysyl-L-valyl-O-benzyl-L-threonyl-O-benzyl-L-seryl-S-p-methoxybenzyl-L-cysteinyl hydroxymethyl polystyrene ester.
Claim 8
Dependent Claim 14 words
The compound of claim 1 which is tert-Butyloxycarbonyl-S-p-methoxybenzyl-L-cysteinyl-N g -tosyl-L-arginyl-Υ-benzyloxy-L-glutamyl-L-phenylalanyl-L-phenylalanyl-D-tryptophyl-N.sup.ε -2-chlorobenzyloxycarbonyl-L-lysyl-L-ε-aminobutyryl-L-phenylalanyl-O-benzyl-L-threonyl-O-benzyl-L-seryl-S-p-methoxybenzyl-L-cysteinyl hydroxymethyl polystyrene ester.

References Cited (Backward Citations)

US4076659A Cited
US4012345A Cited
US4077952A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-07-29 1984-01-28 1984-07-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-07-29 1988-01-28 1988-07-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-07-29 1992-01-28 1992-07-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag